Medical Polylactic Acid - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511244175

Publication Date:

November 7, 2024

Pages:

122

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global market for Medical Polylactic Acid was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Polylactic Acid, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Medical Polylactic Acid by region & country, by Type, and by Application.
The Medical Polylactic Acid market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Polylactic Acid.
麻豆原创 Segmentation
By Company
Musashino Chemical
Total Corbion
BMG
NatureWorks
Shenzhen Esun
Hanshang Group
Sinobiom
Jindan
Hi-Tech Fiber Group
Daigang Biomaterial
Dikang Biomedical
Hisun Biomaterials
BBCA Biochemical
Segment by Type:
L-Polylactic (PLLA)
D-Polylactic (PDLA)
DL-Polylactic (PDLLA)
Segment by Application
Orthopedic Implantable Medical Devices
Medical Suture
Medical Coating
Injectable Plastic Products
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medical Polylactic Acid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Medical Polylactic Acid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Medical Polylactic Acid in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Medical Polylactic Acid Product Introduction
1.2 Global Medical Polylactic Acid 麻豆原创 Size Forecast
1.2.1 Global Medical Polylactic Acid Sales Value (2019-2030)
1.2.2 Global Medical Polylactic Acid Sales Volume (2019-2030)
1.2.3 Global Medical Polylactic Acid Sales Price (2019-2030)
1.3 Medical Polylactic Acid 麻豆原创 Trends & Drivers
1.3.1 Medical Polylactic Acid Industry Trends
1.3.2 Medical Polylactic Acid 麻豆原创 Drivers & Opportunity
1.3.3 Medical Polylactic Acid 麻豆原创 Challenges
1.3.4 Medical Polylactic Acid 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Medical Polylactic Acid Players Revenue Ranking (2023)
2.2 Global Medical Polylactic Acid Revenue by Company (2019-2024)
2.3 Global Medical Polylactic Acid Players Sales Volume Ranking (2023)
2.4 Global Medical Polylactic Acid Sales Volume by Company Players (2019-2024)
2.5 Global Medical Polylactic Acid Average Price by Company (2019-2024)
2.6 Key Manufacturers Medical Polylactic Acid Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Medical Polylactic Acid Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Medical Polylactic Acid
2.9 Medical Polylactic Acid 麻豆原创 Competitive Analysis
2.9.1 Medical Polylactic Acid 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Medical Polylactic Acid Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Polylactic Acid as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 L-Polylactic (PLLA)
3.1.2 D-Polylactic (PDLA)
3.1.3 DL-Polylactic (PDLLA)
3.2 Global Medical Polylactic Acid Sales Value by Type
3.2.1 Global Medical Polylactic Acid Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Medical Polylactic Acid Sales Value, by Type (2019-2030)
3.2.3 Global Medical Polylactic Acid Sales Value, by Type (%) (2019-2030)
3.3 Global Medical Polylactic Acid Sales Volume by Type
3.3.1 Global Medical Polylactic Acid Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Medical Polylactic Acid Sales Volume, by Type (2019-2030)
3.3.3 Global Medical Polylactic Acid Sales Volume, by Type (%) (2019-2030)
3.4 Global Medical Polylactic Acid Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Orthopedic Implantable Medical Devices
4.1.2 Medical Suture
4.1.3 Medical Coating
4.1.4 Injectable Plastic Products
4.1.5 Other
4.2 Global Medical Polylactic Acid Sales Value by Application
4.2.1 Global Medical Polylactic Acid Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Medical Polylactic Acid Sales Value, by Application (2019-2030)
4.2.3 Global Medical Polylactic Acid Sales Value, by Application (%) (2019-2030)
4.3 Global Medical Polylactic Acid Sales Volume by Application
4.3.1 Global Medical Polylactic Acid Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Medical Polylactic Acid Sales Volume, by Application (2019-2030)
4.3.3 Global Medical Polylactic Acid Sales Volume, by Application (%) (2019-2030)
4.4 Global Medical Polylactic Acid Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Medical Polylactic Acid Sales Value by Region
5.1.1 Global Medical Polylactic Acid Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Medical Polylactic Acid Sales Value by Region (2019-2024)
5.1.3 Global Medical Polylactic Acid Sales Value by Region (2025-2030)
5.1.4 Global Medical Polylactic Acid Sales Value by Region (%), (2019-2030)
5.2 Global Medical Polylactic Acid Sales Volume by Region
5.2.1 Global Medical Polylactic Acid Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Medical Polylactic Acid Sales Volume by Region (2019-2024)
5.2.3 Global Medical Polylactic Acid Sales Volume by Region (2025-2030)
5.2.4 Global Medical Polylactic Acid Sales Volume by Region (%), (2019-2030)
5.3 Global Medical Polylactic Acid Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Medical Polylactic Acid Sales Value, 2019-2030
5.4.2 North America Medical Polylactic Acid Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Medical Polylactic Acid Sales Value, 2019-2030
5.5.2 Europe Medical Polylactic Acid Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Medical Polylactic Acid Sales Value, 2019-2030
5.6.2 Asia Pacific Medical Polylactic Acid Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Medical Polylactic Acid Sales Value, 2019-2030
5.7.2 South America Medical Polylactic Acid Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Medical Polylactic Acid Sales Value, 2019-2030
5.8.2 Middle East & Africa Medical Polylactic Acid Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Medical Polylactic Acid Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Medical Polylactic Acid Sales Value
6.2.1 Key Countries/Regions Medical Polylactic Acid Sales Value, 2019-2030
6.2.2 Key Countries/Regions Medical Polylactic Acid Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Medical Polylactic Acid Sales Value, 2019-2030
6.3.2 United States Medical Polylactic Acid Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Medical Polylactic Acid Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Medical Polylactic Acid Sales Value, 2019-2030
6.4.2 Europe Medical Polylactic Acid Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Medical Polylactic Acid Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Medical Polylactic Acid Sales Value, 2019-2030
6.5.2 China Medical Polylactic Acid Sales Value by Type (%), 2023 VS 2030
6.5.3 China Medical Polylactic Acid Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Medical Polylactic Acid Sales Value, 2019-2030
6.6.2 Japan Medical Polylactic Acid Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Medical Polylactic Acid Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Medical Polylactic Acid Sales Value, 2019-2030
6.7.2 South Korea Medical Polylactic Acid Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Medical Polylactic Acid Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Medical Polylactic Acid Sales Value, 2019-2030
6.8.2 Southeast Asia Medical Polylactic Acid Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Medical Polylactic Acid Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Medical Polylactic Acid Sales Value, 2019-2030
6.9.2 India Medical Polylactic Acid Sales Value by Type (%), 2023 VS 2030
6.9.3 India Medical Polylactic Acid Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Musashino Chemical
7.1.1 Musashino Chemical Company Information
7.1.2 Musashino Chemical Introduction and Business Overview
7.1.3 Musashino Chemical Medical Polylactic Acid Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Musashino Chemical Medical Polylactic Acid Product Offerings
7.1.5 Musashino Chemical Recent Development
7.2 Total Corbion
7.2.1 Total Corbion Company Information
7.2.2 Total Corbion Introduction and Business Overview
7.2.3 Total Corbion Medical Polylactic Acid Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Total Corbion Medical Polylactic Acid Product Offerings
7.2.5 Total Corbion Recent Development
7.3 BMG
7.3.1 BMG Company Information
7.3.2 BMG Introduction and Business Overview
7.3.3 BMG Medical Polylactic Acid Sales, Revenue and Gross Margin (2019-2024)
7.3.4 BMG Medical Polylactic Acid Product Offerings
7.3.5 BMG Recent Development
7.4 NatureWorks
7.4.1 NatureWorks Company Information
7.4.2 NatureWorks Introduction and Business Overview
7.4.3 NatureWorks Medical Polylactic Acid Sales, Revenue and Gross Margin (2019-2024)
7.4.4 NatureWorks Medical Polylactic Acid Product Offerings
7.4.5 NatureWorks Recent Development
7.5 Shenzhen Esun
7.5.1 Shenzhen Esun Company Information
7.5.2 Shenzhen Esun Introduction and Business Overview
7.5.3 Shenzhen Esun Medical Polylactic Acid Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Shenzhen Esun Medical Polylactic Acid Product Offerings
7.5.5 Shenzhen Esun Recent Development
7.6 Hanshang Group
7.6.1 Hanshang Group Company Information
7.6.2 Hanshang Group Introduction and Business Overview
7.6.3 Hanshang Group Medical Polylactic Acid Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Hanshang Group Medical Polylactic Acid Product Offerings
7.6.5 Hanshang Group Recent Development
7.7 Sinobiom
7.7.1 Sinobiom Company Information
7.7.2 Sinobiom Introduction and Business Overview
7.7.3 Sinobiom Medical Polylactic Acid Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Sinobiom Medical Polylactic Acid Product Offerings
7.7.5 Sinobiom Recent Development
7.8 Jindan
7.8.1 Jindan Company Information
7.8.2 Jindan Introduction and Business Overview
7.8.3 Jindan Medical Polylactic Acid Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Jindan Medical Polylactic Acid Product Offerings
7.8.5 Jindan Recent Development
7.9 Hi-Tech Fiber Group
7.9.1 Hi-Tech Fiber Group Company Information
7.9.2 Hi-Tech Fiber Group Introduction and Business Overview
7.9.3 Hi-Tech Fiber Group Medical Polylactic Acid Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Hi-Tech Fiber Group Medical Polylactic Acid Product Offerings
7.9.5 Hi-Tech Fiber Group Recent Development
7.10 Daigang Biomaterial
7.10.1 Daigang Biomaterial Company Information
7.10.2 Daigang Biomaterial Introduction and Business Overview
7.10.3 Daigang Biomaterial Medical Polylactic Acid Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Daigang Biomaterial Medical Polylactic Acid Product Offerings
7.10.5 Daigang Biomaterial Recent Development
7.11 Dikang Biomedical
7.11.1 Dikang Biomedical Company Information
7.11.2 Dikang Biomedical Introduction and Business Overview
7.11.3 Dikang Biomedical Medical Polylactic Acid Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Dikang Biomedical Medical Polylactic Acid Product Offerings
7.11.5 Dikang Biomedical Recent Development
7.12 Hisun Biomaterials
7.12.1 Hisun Biomaterials Company Information
7.12.2 Hisun Biomaterials Introduction and Business Overview
7.12.3 Hisun Biomaterials Medical Polylactic Acid Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Hisun Biomaterials Medical Polylactic Acid Product Offerings
7.12.5 Hisun Biomaterials Recent Development
7.13 BBCA Biochemical
7.13.1 BBCA Biochemical Company Information
7.13.2 BBCA Biochemical Introduction and Business Overview
7.13.3 BBCA Biochemical Medical Polylactic Acid Sales, Revenue and Gross Margin (2019-2024)
7.13.4 BBCA Biochemical Medical Polylactic Acid Product Offerings
7.13.5 BBCA Biochemical Recent Development
8 Industry Chain Analysis
8.1 Medical Polylactic Acid Industrial Chain
8.2 Medical Polylactic Acid Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Medical Polylactic Acid Sales Model
8.5.2 Sales Channel
8.5.3 Medical Polylactic Acid Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Musashino Chemical
Total Corbion
BMG
NatureWorks
Shenzhen Esun
Hanshang Group
Sinobiom
Jindan
Hi-Tech Fiber Group
Daigang Biomaterial
Dikang Biomedical
Hisun Biomaterials
BBCA Biochemical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.